Searched for
DRUGMAKER MERCK
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Sun Pharma to buy Organon in $11.75 billion all-cash dealSun Pharmaceutical Industries has agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion,...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Merck to partner with Google Cloud on AI initiativesDrugmaker Merck & Co is joining forces with Google Cloud. They will invest up to one billion dollars over several years. This partnership a...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- Trump administration readies new tariffs on select drugmakers: ReportThe Trump administration is reportedly preparing to impose 100% tariffs on drugmakers that haven't secured deals for lower U.S. prices. Sev...
- Merck braces for Keytruda patent loss with $6.7 billion Terns betMerck is acquiring Terns Pharma for $6.7 billion to strengthen its cancer drug pipeline, aiming to reduce reliance on its blockbuster Keytr...
- US drugmaker Merck to boost workforce in India, executive saysMerck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employe...
- Merck ends development of two potential COVID-19 vaccinesThe drugmaker said Monday that it will focus instead on studying two possible treatments for the virus that also have yet to be approved by...
- Merck KGaA bets on cancer drugs to revitalise German firmMerck KGaA is betting on its oncology pipeline to revitalise the German drugmaker as it sees falling sales from its best-selling medicine, ...
- Sun Pharma Q2 net profit up 15% at Rs 1,572 crore"We also continue to review opportunities to expand and strengthen our global footprint,” said Dilip Shanghvi, managing director, Sun Pharm...
- MNC drug companies like Roche, Merck Serono, Novartis see top deck reshuffleThese companies not only had to battle slow growth but also the fickle stand of Indian government over issues of intellectual property and ...
- Merck ends pact with RanbaxySeparate reports have said the world's 2nd largest drugmaker has now shifted the research programme to Aurigine, a wholly-owned drug discov...
- Merck's 2Q net drops on higher costs, chargesDrugmaker Merck & Co. posts a 52 percent drop in second-quarter net income, due to higher costs for sales, administration and restructuring...
- Drugmaker Merck closing 8 plants, 8 research sitesDrugmaker Merck & Co. said Thursday it is shutting down eight manufacturing plants and eight research sites around the world, including two...
- Merck, Glenmark end cholesterol drug rowCos opt for out-of-court settlement; Merck to refund $20-mn litigation costs.
- Merck Q1 sales rise but profit fall on chargesDrugmaker Merck & Co. says double-digit sales growth for a half-dozen of its top medicines fueled a 7 percent jump in first-quarter sales.
- Vioxx lawsuits pile up in US courtsA Surge of lawsuits has swamped courthouses just ahead of the two-year anniversary of drugmaker Merck pulling its blockbuster painkiller Vi...
- Merck to acquire biotech firm Serono for $13.3 bnGerman drugmaker Merck unveiled a surprise 16.6-bn-Swiss franc ($13.3 bn) deal to buy Swiss biotech firm Serono on Thursday, creating a new...
Load More
